7544 Nucleoside phosphorylase/phosphoribosyltransferase catalytic domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 8 | 8.2 | 0.97× | q = 1.00 | |
| Benzenoids | 6 | 1.2 | 4.90× | not tested | |
| Organic nitrogen compounds | 1 | 0.5 | 1.87× | not tested | |
| Organic oxygen compounds | 6 | 3.3 | 1.80× | not tested | |
| Homogeneous non-metal compounds | 6 | 3.6 | 1.66× | not tested | |
| Organoheterocyclic compounds | 3 | 2.6 | 1.16× | not tested | |
| Nucleosides, nucleotides, and analogues | 5 | 4.6 | 1.08× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01632 | PRP | 5-O-phosphono-alpha-D-ribofuranosyl diphosphate | 69 |
| DB04166 | BE2 | Anthranilic acid | 15 |
| DB00936 | SAL | Salicylic acid | 4 |
| DB03462 | TDR | Thymine | 4 |
| DB04485 | THM | Thymidine | 3 |
| DB00131 | AMP | Adenosine phosphate | 2 |
| DB02097 | CTN | Cytidine | 2 |
| DB02745 | URI | Uridine | 2 |
| DB03554 | IUR | 5-Iodouracil | 2 |
| DB00495 | AZZ | Zidovudine | 1 |
| DB02219 | CXS | 3-(cyclohexylamino)propanesulfonic acid | 1 |
| DB03419 | URA | Uracil | 1 |
| DB09343 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 73 |
| PRP | 1-O-pyrophosphono-5-O-phosphono-alpha-D-ribofuranose | 69 |
| BE2 | 2-AMINOBENZOIC ACID | 15 |
| POP | PYROPHOSPHATE 2- | 10 |
| 17C | 2,2'-iminodibenzoic acid | 6 |
| FA0 | 2-amino-4-fluorobenzoic acid | 6 |
| MNmetal | MANGANESE (II) ION | 6 |
| 14B | 2-amino-3,5-dimethylbenzoic acid | 4 |
| 17D | 2-benzylbenzoic acid | 4 |
| CL | CHLORIDE ION | 4 |
| SAL | 2-HYDROXYBENZOIC ACID | 4 |
| TA7 | 4,4,4-trifluoro-1-(4-methoxyphenyl)butane-1,3-dione | 4 |
| 7P3 | 2-[(2-carboxyphenyl)amino]-5-[(5-phosphonopentyl)oxy]benzoic acid | 3 |
| NAmetal | SODIUM ION | 3 |
| TDR | THYMINE | 3 |
| THM | THYMIDINE | 3 |
| 17N | 8-methoxyphenanthro[3,4-d][1,3]dioxole-5,6-dicarboxylic acid | 2 |
| 3F0 | 2-azanyl-3-fluoranyl-benzoic acid | 2 |
| 3M0 | 2-azanyl-3-methyl-benzoic acid | 2 |
| 4M0 | 2-azanyl-4-methyl-benzoic acid | 2 |